FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

FDA expands use of Xarelto to treat, reduce recurrence of blood clots

Filed under: drug treatment news 2011

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment …
Read more on FDA.gov

Pfizer Treatment: More Bang for the Buck

Filed under: drug treatment news 2011

The third quarter of 2011 was the last one in which Pfizer still had full patent protection for cholesterol treatment Lipitor, then the world's best-selling drug. Despite losing it since, earnings per share are seen at 52 cents, compared with 48 cents …
Read more on Wall Street Journal